Health Innovations: New Cures, New Capital
Many exciting biomed startups have found a home in the venture capital market. “Public investors are risk averse these days,” says VentureWire’s Tom Salemi. “They only want to bet on as sure a thing as possible. That’s not usually the case with biotech.” PodTech’s Jason Lopez chatted with Tom by phone and filed this preview of the the upcoming Health Care Innovations conference (September 12 & 13, 2006) in Redwood City, CA.